Cargando…

Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study

Detalles Bibliográficos
Autores principales:	Henderson, Jacob J., Das, Anirban, Morgenstern, Daniel A., Sudhaman, Sumedha, Bianchi, Vanessa, Chung, Jill, Negm, Logine, Edwards, Melissa, Kram, David E., Osborn, Michael, Hawkins, Cynthia, Bouffet, Eric, Cho, Yoon-Jae, Tabori, Uri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2022
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906457/ https://www.ncbi.nlm.nih.gov/pubmed/35235414 http://dx.doi.org/10.1200/PO.21.00286

Ejemplares similares

IMMU-14. IMMUNE CHECKPOINT INHIBITOR THERAPY FOR TREATMENT OF SYNCHRONOUS CANCERS IN PAEDIATRIC PATIENTS WITH CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY
por: Henderson, Jacob, et al.
Publicado: (2020)

MDB-12. TRANS-SPECIES ANALYSIS OF REPLICATION-REPAIR DEFICIENT (RRD) MEDULLOBLASTOMA AND RESPONSE TO IMMUNE-CHECKPOINT INHIBITION: AN IRRDC REPORT
por: Das, Anirban, et al.
Publicado: (2023)

HGG-26. GENOMIC AND IMMUNE ANALYSIS OF PRIMARY REPLICATION-REPAIR DEFICIENT (RRD) GLIOMAS REVEALS THREE SUBGROUPS WITH DISTINCT DRIVERS AND RESPONSE TO IMMUNOTHERAPY: AN IRRDC REPORT
por: Fernandez, Nicholas R, et al.
Publicado: (2023)

IMMU-08. SALVAGE IMMUNOTHERAPIES FOR REPLICATION REPAIR DEFICIENT (RRD) HIGH-GRADE GLIOMA FAILING ANTI-PD1 MONOTHERAPY: AN IRRDC REPORT
por: Das, Anirban, et al.
Publicado: (2023)

HGG-27. THE IMPACT OF MISMATCH REPAIR DEFICIENCY ON GLIOMAS IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS; A REPORT FROM THE IRRDC AND THE GLIOMA TASK FORCE
por: Negm, Logine, et al.
Publicado: (2023)

MODL-25. REPLICATION REPAIR DEFICIENT MOUSE MODELS PROVIDE INSIGHT ON HYPERMUTANT BRAIN TUMOURS, MECHANISMS OF IMMUNE EVASION, AND COMBINATORIAL IMMUNOTHERAPY
por: Galati, Melissa, et al.
Publicado: (2020)

IMMU-13. Dual CTLA4/ PD-1 blockade improves survival for replication-repair deficient high-grade gliomas failing single agent PD-1 inhibition: An IRRDC study
por: Das, Anirban, et al.
Publicado: (2022)

MBRS-54. POOR SURVIVAL IN REPLICATION REPAIR DEFICIENT HYPERMUTANT MEDULLOBLASTOMA AND CNS EMBRYONAL TUMORS: A REPORT FROM THE INTERNATIONAL RRD CONSORTIUM
por: Das, Anirban, et al.
Publicado: (2020)

Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency
por: Das, Anirban, et al.
Publicado: (2023)

IMMU-18. FAVORABLE OUTCOME IN REPLICATION REPAIR DEFICIENT HYPERMUTANT BRAIN TUMORS TO IMMUNE CHECKPOINT INHIBITION: AN INTERNATIONAL RRD CONSORTIUM REGISTRY STUDY
por: Bouffet, Eric, et al.
Publicado: (2020)

Recurrent posterior fossa group A (PFA) ependymoma in a young child with constitutional mismatch repair deficiency (CMMRD)
por: Briggs, Mayen, et al.
Publicado: (2022)

BIOL-18. NEWLY DEVELOPED REPLICATION REPAIR DEFICIENT (RRD) MOUSE MODELS PROVIDE INSIGHTS INTO MEDULLOBLASTOMA/GLIOMAGENESIS AND RESPONSE TO IMMUNOTHERAPY
por: Aamir, Zoya, et al.
Publicado: (2023)

Checkpoint kinase 1 negatively regulates somatic hypermutation
por: Frankenberger, Samantha, et al.
Publicado: (2014)

Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
por: Aslan, Katrin, et al.
Publicado: (2020)

Immune checkpoint inhibitor in recurrent hypermutated glioblastoma with POLE mutation
por: Sathornsumetee, Sith, et al.
Publicado: (2021)

Pakistan National Guidelines for Pediatric High-Grade Gliomas
por: Bashir, Farrah, et al.
Publicado: (2023)

Immune Checkpoint Inhibition as Primary Adjuvant Therapy for an IDH1-Mutant Anaplastic Astrocytoma in a Patient with CMMRD: A Case Report—Usage of Immune Checkpoint Inhibition in CMMRD
por: Rittberg, Rebekah, et al.
Publicado: (2021)

IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells
por: Kehl, Niklas, et al.
Publicado: (2022)

Detection of temozolomide-induced hypermutation and response to PD-1 checkpoint inhibitor in recurrent glioblastoma
por: Daniel, Paul, et al.
Publicado: (2022)

MPC-14 BRAF V600E MUTANT OLIGODENDROGLIOMA-LIKE TUMORS WITH CHROMOSOMAL INSTABILITY IN ADOLESCENTS AND YOUNG ADULTS
por: Fukuoka, Kohei, et al.
Publicado: (2019)

Pediatric low-grade glioma in the era of molecular diagnostics
por: Ryall, Scott, et al.
Publicado: (2020)

Clinical and economic impact of molecular testing for BRAF fusion in pediatric low-grade Glioma
por: Rios, Juan David, et al.
Publicado: (2022)

HIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation
por: Rawson, Jonathan M O, et al.
Publicado: (2015)

The Promotion of V Region Hypermutation
por: Scharff, Matthew D., et al.
Publicado: (1997)

Hypermutation takes the driver’s seat
por: Schlesner, Matthias, et al.
Publicado: (2015)

Hypermutation in single-stranded DNA
por: Saini, Natalie, et al.
Publicado: (2020)

Tandem Substitutions in Somatic Hypermutation
por: Sepúlveda-Yáñez, Julieta H., et al.
Publicado: (2022)

Rare cases of medulloblastoma with hypermutation
por: Bagchi, Aditi, et al.
Publicado: (2021)

Mechanisms and therapeutic implications of hypermutation in gliomas
por: Touat, Mehdi, et al.
Publicado: (2020)

Optic Pathway Glioma in Children with Neurofibromatosis Type 1: A Multidisciplinary Entity, Posing Dilemmas in Diagnosis and Management Multidisciplinary Management of Optic Pathway Glioma in Children with Neurofibromatosis Type 1
por: Lohkamp, Laura-Nanna, et al.
Publicado: (2022)

Attracting AID to targets of somatic hypermutation
por: Tanaka, Atsushi, et al.
Publicado: (2010)

Hypermutation and microsatellite instability in gastrointestinal cancers
por: Yuza, Kizuki, et al.
Publicado: (2017)

Hypermutated phenotype in gliosarcoma of the spinal cord
por: Hong, Christopher S., et al.
Publicado: (2021)

Genetic and chemotherapeutic influences on germline hypermutation
por: Kaplanis, Joanna, et al.
Publicado: (2022)

Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies
por: Xu-Monette, Zijun Y., et al.
Publicado: (2019)

AID function in somatic hypermutation and class switch recombination: AID function in somatic hypermutation and class switch recombination
por: Yu, Kefei
Publicado: (2022)

Plant shoots exhibit synchronized oscillatory motions
por: Ciszak, Marzena, et al.
Publicado: (2016)

LGG-41. The clinical and molecular landscape of gliomas in adolescents and young adults
por: Bennett, Julie, et al.
Publicado: (2022)

Identifying protein–protein interactions in somatic hypermutation
por: Goodman, Myron F., et al.
Publicado: (2005)

A Role for PCNA Ubiquitination in Immunoglobulin Hypermutation
por: Arakawa, Hiroshi, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_do0ps3gtvbadsieg3ra0m9sdfu